Search Results - "Pestana, Karen Goldsmith"
-
1
Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation
Published in European journal of immunology (01-05-2010)“…In visceral leishmaniasis, the draining LN (DLN) is the initial site for colonization and establishment of infection after intradermal transmission by the sand…”
Get full text
Journal Article -
2
Leishmania pifanoi Proteoglycolipid Complex P8 Induces Macrophage Cytokine Production through Toll-Like Receptor 4
Published in Infection and Immunity (01-05-2008)“…The P8 proteoglycolipid complex (P8 PGLC) is a glyconjugate expressed by Leishmania mexicana complex parasites. We previously have shown that vaccination with…”
Get full text
Journal Article -
3
The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation
Published in Immunity (Cambridge, Mass.) (16-02-2016)“…Exposure to a plethora of environmental challenges commonly triggers pathological type 2 cell-mediated inflammation. Here we report the pathological role of…”
Get full text
Journal Article -
4
Murine model of chronic L. (Viannia) panamensis infection: Role of IL-13 in disease
Published in European journal of immunology (01-10-2010)“…Leishmania (Viannia) organisms are the most prevalent etiologic agents of human cutaneous leishmaniasis in the Americas. Nevertheless, our knowledge of the…”
Get full text
Journal Article -
5
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)
Published in PLoS neglected tropical diseases (01-06-2011)“…Leishmania (Viannia) parasites present particular challenges, as human and murine immune responses to infection are distinct from other Leishmania species,…”
Get full text
Journal Article -
6
Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania
Published in European journal of immunology (01-03-2008)“…Heterologous prime-boost vaccination employing DNA-vaccinia virus (VACV) modality using the Leishmania homologue of receptors for activated C kinase (LACK)…”
Get full text
Journal Article -
7
Heterologous Prime-Boost Vaccination with the LACK Antigen Protects against Murine Visceral Leishmaniasis
Published in Infection and Immunity (01-08-2005)“…This study reports the efficacy of a heterologous prime-boost vaccination using DNA and vaccinia viruses (Western Reserve [WR] virus and modified [attenuated]…”
Get full text
Journal Article -
8
Mechanisms of pathogenesis: differences amongst Leishmania species
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01-04-2002)“…One of the features of the genus Leishmania is the diversity of tropism/disease resulting from infection. With notable exceptions, the form (visceral,…”
Get full text
Journal Article -
9
The Immunologically Protective P-4 Antigen ofLeishmania Amastigotes
Published in The Journal of biological chemistry (01-12-2000)“…The purified membrane-associated Leishmania pifanoi amastigote protein P-4 has been shown to induce protective immunity against infection and to elicit…”
Get full text
Journal Article -
10
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model
Published in Biomaterials (01-11-2016)“…Abstract Leishmania (Viannia) panamensis ( L. (V.) panamensis ) is a species of protozoan parasites that causes New World leishmaniasis, which is characterized…”
Get full text
Journal Article -
11
The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection
Published in The Journal of immunology (1950) (15-09-2014)“…Leishmania (Viannia) parasites are etiological agents of cutaneous leishmaniasis in the New World. Infection is characterized by a mixed Th1/Th2 inflammatory…”
Get full text
Journal Article -
12
Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness
Published in Bioorganic & medicinal chemistry letters (01-11-2016)“…[Display omitted] Trypanosoma brucei are protozoan parasites that cause African sleeping sickness in humans (also known as Human African Trypanosomiasis—HAT)…”
Get full text
Journal Article -
13
Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection
Published in Infection and immunity (01-03-2017)“…Infection by ( ) , the predominant etiologic agent for cutaneous leishmaniasis in Colombia, is characterized by a chronic mixed inflammatory response. Current…”
Get full text
Journal Article -
14
A Scaffold Protein, AHNAK1, Is Required for Calcium Signaling during T Cell Activation
Published in Immunity (Cambridge, Mass.) (01-01-2008)“…Engagement of the T cell antigen receptor (TCR) during antigen presentation initiates a coordinated action of a large number of signaling proteins and ion…”
Get full text
Journal Article -
15
Cutaneous leishmaniasis is regulated by Wnt antagonist Dkk-1 from activated platelets (MPF7P.715)
Published in The Journal of immunology (1950) (01-05-2015)“…Cutaneous leishmaniasis is a chronic non-healing skin inflammatory disease present in many countries. Here we show that the Wnt antagonist Dkk-1 is secreted…”
Get full text
Journal Article -
16
The role of regulatory T cells in the Leishmania (Viannia) panamensis mouse model: a target for immunotherapy. (P3091)
Published in The Journal of immunology (1950) (01-05-2013)“…Leishmania (Viannia) parasites are etiological agents of cutaneous leishmaniasis in the New World. Infection in humans is characterized by mixed Th1/Th2 and…”
Get full text
Journal Article -
17
TLR1/2 activation during heterologous prime-boost vaccination
Published in PLoS neglected tropical diseases (01-06-2011)“…Background: Leishmania (Viannia) parasites present particular challenges, as human and murine immune responses to infection are distinct from other Leishmania…”
Get full text
Journal Article -
18
NKTi cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania
Published in European journal of immunology (01-03-2008)“…Heterologous prime-boost vaccination employing DNA-vaccinia virus (VACV) modality using the LACK (p36) antigen ( Leishmania homologue of receptors for…”
Get full text
Journal Article -
19
The immunologically protective P-4 antigen of Leishmania amastigotes. A developmentally regulated single strand-specific nuclease associated with the endoplasmic reticulum
Published in The Journal of biological chemistry (01-12-2000)“…The purified membrane-associated Leishmania pifanoi amastigote protein P-4 has been shown to induce protective immunity against infection and to elicit…”
Get full text
Journal Article